Form 4: Nkarta President Nadir Mahmood Granted 123,500 Stock Options

Nkarta, Inc. President Nadir Mahmood was granted 123,500 stock options with an exercise price of $1.83, vesting over two years.

Summary

• Nadir Mahmood, President of Nkarta, Inc. (NKTX), was granted 123,500 stock options on June 5, 2025.
• The stock options have an exercise price of $1.83 per share.
• The options are scheduled to vest in two tranches: 40% on June 5, 2026, and the remaining 60% on June 5, 2027.
• The expiration date for these stock options is June 4, 2035.
• Following this transaction, Mr. Mahmood beneficially owns 123,500 derivative securities directly.
• Mr. Mahmood also executed a Power of Attorney on June 8, 2025, authorizing certain individuals to file SEC reports on his behalf.

Sentiment

Score: 6

Explanation: The grant of stock options to a key executive is a positive for aligning management incentives with shareholder interests, but it is a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of stock options aligns the interests of President Nadir Mahmood with those of shareholders, incentivizing long-term company performance.
• The options have a long expiration date (June 4, 2035), providing a significant window for potential value realization.
• The Power of Attorney streamlines the process for filing required SEC documents for the executive, ensuring compliance.

Future Outlook

The document indicates future vesting dates for the stock options on June 5, 2026, and June 5, 2027, which are standard future events for equity compensation.

Industry Context

This is a routine insider transaction filing (Form 4) for executive compensation. Such grants are common practice across various industries, including biotechnology, to incentivize executive performance and retention. It does not provide broader industry trends.

Comparison to Industry Standards

• The grant of stock options to a senior executive like the President is a standard form of executive compensation in the biotechnology and pharmaceutical industries, aligning executive incentives with shareholder value creation.
• The vesting schedule (40% in one year, 60% in two years) is a common multi-year vesting approach, designed to encourage long-term commitment and performance.
• The exercise price being fixed at the grant date is typical for stock options.

Corporate Governance

Related Party Transactions

• The stock option grant is a transaction between the company and an executive, which is a form of related party transaction, but it is a standard compensation event.

Stakeholder Impact

• Shareholders: The option grant aligns executive incentives with shareholder interests, potentially leading to better long-term performance.
• Management: Nadir Mahmood receives additional equity compensation, incentivizing his continued performance and retention.

Next Steps

• The stock options are scheduled to vest 40% on June 5, 2026.
• The remaining 60% of the stock options are scheduled to vest on June 5, 2027.

Key Dates

Keywords

Nkarta Inc., NKTX, Stock Options, Insider Transaction, Form 4, Executive Compensation, Nadir Mahmood, Equity Grant, Biotechnology, Pharmaceuticals